These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 38406587)

  • 1. The effect of human PBMCs immobilization on their Аβ42 aggregates-dependent proinflammatory state on a cellular model of Alzheimer's disease.
    Kot K; Kot Y; Kurbanov R; Andriiash H; Tigunova O; Blume Y; Shulga S
    Front Neurosci; 2024; 18():1325287. PubMed ID: 38406587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of β-amyloid peptide 42 on the dynamics of expression and formation of Аβ40, IL -1β, TNF α, IL -6, IL -10 by peripheral blood mononuclear cells in vitro and its correction by curcumin.
    Sokolik VV; Koliada OK; Shulga SM
    Ukr Biochem J; 2016; 88(1):109-18. PubMed ID: 29227593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of curcumin on accumulation in mononuclear cells and secretion in incubation medium of Аβ(40) and cytokines under local excess of Аβ(42)-homoaggregates.
    Sokolik VV; Shulga SM
    Ukr Biochem J; 2016; 88(3):83-91. PubMed ID: 29235333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic immune responses in Alzheimer's disease: in vitro mononuclear cell activation and cytokine production.
    Pellicanò M; Bulati M; Buffa S; Barbagallo M; Di Prima A; Misiano G; Picone P; Di Carlo M; Nuzzo D; Candore G; Vasto S; Lio D; Caruso C; Colonna-Romano G
    J Alzheimers Dis; 2010; 21(1):181-92. PubMed ID: 20413861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cumulative effect of the combined action of miR-101 and curcumin in a liposome on a model of Alzheimer's disease in mononuclear cells.
    Sokolik VV; Berchenko OG
    Front Cell Neurosci; 2023; 17():1169980. PubMed ID: 37153632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroinflammation and amyloid-beta 40 are associated with reduced serotonin transporter (SERT) activity in a transgenic model of familial Alzheimer's disease.
    Metaxas A; Anzalone M; Vaitheeswaran R; Petersen S; Landau AM; Finsen B
    Alzheimers Res Ther; 2019 May; 11(1):38. PubMed ID: 31043179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amyloid-Beta Peptides 40 and 42 Employ Distinct Molecular Pathways for Cell Entry and Intracellular Transit at the Blood-Brain Barrier Endothelium.
    Wang Z; Sharda N; Omtri RS; Li L; Kandimalla KK
    Mol Pharmacol; 2023 Nov; 104(5):203-213. PubMed ID: 37541759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Linking Alzheimer's Disease and Type 2 Diabetes: Characterization and Inhibition of Cytotoxic Aβ and IAPP Hetero-Aggregates.
    Al Adem K; Shanti A; Srivastava A; Homouz D; Thomas SA; Khair M; Stefanini C; Chan V; Kim TY; Lee S
    Front Mol Biosci; 2022; 9():842582. PubMed ID: 35372522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aberrant Co-localization of Synaptic Proteins Promoted by Alzheimer's Disease Amyloid-β Peptides: Protective Effect of Human Serum Albumin.
    Domínguez-Prieto M; Velasco A; Vega L; Tabernero A; Medina JM
    J Alzheimers Dis; 2017; 55(1):171-182. PubMed ID: 27662292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Wild-type, Flemish, and Dutch amyloid-β exhibit different cytotoxicities depending on Aβ40 to Aβ42 interaction time and concentration ratio.
    Shahnawaz M; Sharoar MG; Shin SY; Park IS
    J Pept Sci; 2013 Sep; 19(9):545-53. PubMed ID: 23853087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in the cellular uptake and intracellular itineraries of amyloid beta proteins 40 and 42: ramifications for the Alzheimer's drug discovery.
    Omtri RS; Davidson MW; Arumugam B; Poduslo JF; Kandimalla KK
    Mol Pharm; 2012 Jul; 9(7):1887-97. PubMed ID: 22574751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maysin and Its Flavonoid Derivative from Centipedegrass Attenuates Amyloid Plaques by Inducting Humoral Immune Response with Th2 Skewed Cytokine Response in the Tg (APPswe, PS1dE9) Alzheimer's Mouse Model.
    Song Y; Kim HD; Lee MK; Hong IH; Won CK; Bai HW; Lee SS; Lee S; Chung BY; Cho JH
    PLoS One; 2017; 12(1):e0169509. PubMed ID: 28072821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcium-sensing receptor antagonist (calcilytic) NPS 2143 specifically blocks the increased secretion of endogenous Aβ42 prompted by exogenous fibrillary or soluble Aβ25-35 in human cortical astrocytes and neurons-therapeutic relevance to Alzheimer's disease.
    Armato U; Chiarini A; Chakravarthy B; Chioffi F; Pacchiana R; Colarusso E; Whitfield JF; Dal Prà I
    Biochim Biophys Acta; 2013 Oct; 1832(10):1634-52. PubMed ID: 23628734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroprotective effect of CPCGI on Alzheimer's disease and its mechanism.
    Wang X; Zhao J
    Mol Med Rep; 2020 Jan; 21(1):115-122. PubMed ID: 31939621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cross-seeding between Aβ40 and Aβ42 in Alzheimer's disease.
    Tran J; Chang D; Hsu F; Wang H; Guo Z
    FEBS Lett; 2017 Jan; 591(1):177-185. PubMed ID: 27981583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alzheimer's Aβ42 and Aβ40 peptides form interlaced amyloid fibrils.
    Gu L; Guo Z
    J Neurochem; 2013 Aug; 126(3):305-11. PubMed ID: 23406382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor Necrosis Factor-α-Mediated Metaplastic Inhibition of LTP Is Constitutively Engaged in an Alzheimer's Disease Model.
    Singh A; Jones OD; Mockett BG; Ohline SM; Abraham WC
    J Neurosci; 2019 Nov; 39(46):9083-9097. PubMed ID: 31570539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural variation in amyloid-β fibrils from Alzheimer's disease clinical subtypes.
    Qiang W; Yau WM; Lu JX; Collinge J; Tycko R
    Nature; 2017 Jan; 541(7636):217-221. PubMed ID: 28052060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In silico investigation on the inhibition of Aβ
    Dutta M; Mattaparthi VSK
    J Biomol Struct Dyn; 2018 Feb; 36(3):741-752. PubMed ID: 28278027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective acetyl- and butyrylcholinesterase inhibitors reduce amyloid-β ex vivo activation of peripheral chemo-cytokines from Alzheimer's disease subjects: exploring the cholinergic anti-inflammatory pathway.
    Reale M; Di Nicola M; Velluto L; D'Angelo C; Costantini E; Lahiri DK; Kamal MA; Yu QS; Greig NH
    Curr Alzheimer Res; 2014; 11(6):608-22. PubMed ID: 24359497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.